Skip to content
OpenCapital
Get started

Envoy Medical COCH EBITDA margin

EBITDA margin at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
7.4%+0.4pp

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K—
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%—
Debt / equity0.1×—
Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

ebitda/total revenue=-9,747%

Based on trailing twelve months.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's EBITDA margin?
Envoy Medical (COCH) reported EBITDA margin of -9,747% in Q1 2026.
How has Envoy Medical's EBITDA margin changed year-over-year?
Envoy Medical's EBITDA margin decreased by 7.2% year-over-year, from -9,094.3% to -9,747%.
What is the long-term trend for Envoy Medical's EBITDA margin?
Over 2 years (2023 to 2025), Envoy Medical's EBITDA margin has grown at a 25.7% compound annual growth rate (CAGR), from -5,767.7% to -9,115.4%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.